INTERNATIONAL PATENT: LUNIT INC., NATIONAL CANCER CENTER FILES APPLICATION FOR "METHOD AND DEVICE FOR PREDICTING CANCER TREATMENT RESPONSE TO IMMUNE CHECKPOINT INHIBITOR"

GENEVA, Nov. 18 -- LUNIT INC. (5F, 374 Gangnam-daero,Gangnam-guSeoul 06241), NATIONAL CANCER CENTER (1-1, Tsukiji 5-chomeChuo-ku, Tokyo 104-0045) filed a patent application (PCT/KR2025/006276) for "METHOD AND DEVICE FOR PREDICTING CANCER TREATMENT RESPONSE TO IMMUNE CHECKPOINT INHIBITOR" on May 09, 2025. With publication no. WO/2025/234833, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): OCK, Chan-Young (5F, 374 Gangnam-daero,Gangnam-guSeoul 06241), SONG, Sanghoon (5F, 374 Gangnam-daero,Gangnam-guSeoul 06241), BANDO, Hide...